• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.98% Nasdaq Down 0.63%

    GenVec, Inc. (GNVC)

    -NasdaqCM
    2.40 Down 0.08(3.23%) 1:16PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.48
    Open:2.39
    Bid:2.37 x 100
    Ask:2.54 x 200
    1y Target Est:8.50
    Beta:3.1
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:2.32 - 2.41
    52wk Range:1.61 - 4.67
    Volume:7,316
    Avg Vol (3m):32,822
    Market Cap:41.45M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GNVC

    Comparison

    Symbol% ChgMkt Cap
    GNVCDown 3.23%41.45M
    MRKDown 0.68%165.44B
    NVSUp 0.05%250.69B
    SNYDown 0.89%139.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.36
    Quarterly EPS Est (Jun-15) :-0.10
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GenVec, Inc., a clinical-stage biopharmaceutical company, focuses on using its adenovector gene delivery platform to develop a pipeline of therapeutics and vaccines in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback